Stentys Reports First Quarter 2015 Revenues Rose 28%

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS (Paris:STNT) (FR0010949404 — STNT), a medical technology company commercializing the world's first and only Self-Apposing® coronary stent, today announces revenues for the first quarter of 2015.

Help employers find you! Check out all the jobs and post your resume.